Pain Management
Pharma company announces U.S. launch of extended-release postop pain drug
Published in Biotech Business Week, January 3rd, 2005
DepoDur, which was approved by the U.S. Food & Drug Administration (FDA) on May 18, 2004, is SkyePharma's single dose sustained-release injectable formulation of morphine for the relief of pain after major surgery.
Endo is SkyePharma's licensee for DepoDur in North America.
SkyePharma PLC develops pharmaceutical products that provide easier-to-use drug formulations.
This article was prepared by Biotech Business Week...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Blood Brain Barrier
Contrast agent for central nervous system gets FDA approval - Cancer Therapy
Pivotal phase III trial to begin for new stem cell transplant drug candidate - Dura Substitute
U.S. FDA clears DuraMatrix Collagen Dura Substitute Membrane - Mergers & Acquisitions
Guilford to obtain exclusive worldwide ownership of AQUAVAN prodrug technology - Pulmonary Embolism
FDA grants clearance for Triage D-Dimer Test - Vein Graft Failure
Results reported from edifoligide phase III trial for peripheral bypass graft - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
